(Q33162387)

English

Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy

scientific article published on 20 February 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

heart arrhythmia

0 references

hypertrophic cardiomyopathy

1 reference

based on heuristic

inferred from title

9

object named as

Thor Edvardsen

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Vibeke M Almaas

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Kristina H Haugaa

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Erik H Strøm

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Helge Scott

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Christen P Dahl

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Trond P Leren

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Odd R Geiran

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Knut Endresen

8

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Svend Aakhus

10

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Jan Peder Amlie

11

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

20 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1319-1327

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the Ameri

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

The case for myocardial ischemia in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Obstruction to left ventricular outflow. Current concepts of management and operative treatment

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Yield of genetic testing in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Hypertrophic cardiomyopathy in 2012

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Transmural Differences in Myocardial Contraction in Long-QT Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT028

21 January 2018

Identifiers

10.1093/EUROPACE/EUT028

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33162387&oldid=2258022651"